• Myeloid Differentiation Primary Response 88 (MYD88) Gene Mutation Analysis
  • Desmethylclomipramine, Urine
  • Cotinine, Urine
  • Delta-type Opioid Receptor 1 (OPRD1) Genotyping
  • Corynebacterium diphtheriae, Culture
  • Alpha Fetoprotein (AFP), Tumor Marker, Serum/Plasam
  • Mucopolysaccharides (MPS), Acid, Quantitative, Urine
  • Hematocrit/Microhematocrit
  • Oncomineā„¢ Dx Target Test
  • Cystatin C with Estimated GFR, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Hematolymphoid Neoplasm Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Hematolymphoid Neoplasm Gene Mutation Panel, NGS
Medical Test

Interpretation
Access to Hematolymphoid Neoplasm Gene Mutation Panel, NGS is restricted.